Physician profile
John A Cowan
NPI 1588786669
$3,240,587.49
in general payments reported to CMS, 2019-2025
17 companies · $609K in 2025
The $609K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491K · 2020: $367K · 2021: $327K · 2022: $275K · 2023: $581K · 2024: $591K · 2025: $609K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.8M · Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,780,849.59 |
| Food and Beverage | $188.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,379,870.31 | 2021-2025 | Pivox Oblique Lateral Spinal System, Divergence Anterior Cervical Fusion System, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $856,139.00 | 2019-2020 | |
| Globus Medical, INC. | $4,045.59 | 2019-2025 | Fortify / Fortify-I, Fortify, Fortify |
| Ge Healthcare | $118.57 | 2019-2020 | |
| Xtant Medical INC | $72.35 | 2023 | |
| Olympus America INC. | $64.29 | 2020 | |
| Abbvie INC. | $63.62 | 2019-2024 | Ubrelvy |
| Supernus Pharmaceuticals, INC. | $61.74 | 2019-2020 | |
| Si-Bone, INC. | $30.85 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $23.18 | 2023 | Austedo |
| Aquestive Therapeutics, INC. | $20.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.77 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $13.42 | 2019 | |
| Neurocrine Biosciences, INC. | $12.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.30 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $10.90 | 2019 | |
| Spineology INC. | $10.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.